The CB1 Neutral Antagonist Tetrahydrocannabivarin Reduces Default Mode Network and Increases Executive Control Network Resting State Functional Connectivity in Healthy Volunteers

BACKGROUND: The cannabinoid cannabinoid type 1 (CB1) neutral antagonist tetrahydrocannabivarin (THCv) has been suggested as a possible treatment for obesity, but without the depressogenic side-effects of inverse antagonists such as Rimonabant. However, how THCv might affect the resting state functio...

Descripción completa

Detalles Bibliográficos
Autores principales: Rzepa, Ewelina, Tudge, Luke, McCabe, Ciara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4772823/
https://www.ncbi.nlm.nih.gov/pubmed/26362774
http://dx.doi.org/10.1093/ijnp/pyv092

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4772823/
https://www.ncbi.nlm.nih.gov/pubmed/26362774
http://dx.doi.org/10.1093/ijnp/pyv092

Ejemplares similares